文献速递瓣膜外科

二尖瓣手术合并房颤外科消融的围术期与中期结局:回顾性分析

Perioperative and mid-term outcomes of mitral valve surgery with and without concomitant surgical ablation for atrial fibrillation: a retrospective analysis.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2024-01-01

该回顾性研究纳入2018年1月至2023年2月接受二尖瓣手术的400例患者,按房颤及是否行外科消融分为无房颤组、房颤未消融组和房颤消融组。结果显示,房颤未消融组死亡率(8.3%)和起搏器植入率(15.6%)均高于无房颤组(2.2%、5.7%)和房颤消融组(3.2%、7.9%);房颤消融组结局与无房颤组相似。结论认为二尖瓣手术合并房颤时应考虑同期外科消融。

要点

  • 房颤未消融组死亡率8.3%,高于无房颤组2.2%和房颤消融组3.2%(P=0.027)。
  • 房颤未消融组起搏器植入率15.6%,高于无房颤组5.7%和房颤消融组7.9%(P=0.011)。
  • 房颤消融组复合不良事件发生率9.5%,与无房颤组9.6%相似,低于未消融组20.2%。

核心结论

  • 二尖瓣手术合并房颤时,同期行外科消融的患者中期结局与无术前房颤患者相似,而未消融的房颤患者死亡率和起搏器植入率更高。

研究设计与样本

  • 回顾性分析2018年1月至2023年2月接受二尖瓣手术的400例患者,分为无房颤组、房颤未消融组和房颤消融组,比较围术期及中期结局。

主要发现

  • 术前房颤发生率为43%,平均随访1.8年(标准差1.1)。
  • 死亡率:无房颤组2.2% vs 房颤未消融组8.3% vs 房颤消融组3.2%(P=0.027)。
  • 起搏器植入率:无房颤组5.7% vs 房颤未消融组15.6% vs 房颤消融组7.9%(P=0.011)。
  • 复合不良事件(死亡、出血、卒中)发生率:无房颤组9.6% vs 房颤未消融组20.2% vs 房颤消融组9.5%(P=0.018),最高见于房颤未消融组。

临床怎么用

  • 二尖瓣手术合并房颤时,可考虑同期行外科消融,以改善中期结局。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We retrospectively analysed perioperative and mid-term outcomes for patients undergoing mitral valve surgery with and without atrial fibrillation. METHODS: Patients who underwent mitral valve surgery between January 2018 and February 2023 were included and categorized into 3 groups: 'No AF' (no documented atrial fibrillation), 'AF no SA' (atrial fibrillation without surgical ablation) and 'AF and SA' (atrial fibrillation with concomitant surgical ablation). Groups were compared for perioperative and mid-term outcomes, including mortality, stroke, bleeding and pacemaker implantation. A P-value <0.05 was considered statistically significant. RESULTS: Of the 400 patients included, preoperative atrial fibrillation was present in 43%. Mean follow-up was 1.8 (standard deviation: 1.1) years. The patients who underwent surgical ablation for atrial fibrillation exhibited similar overall outcomes compared to patients without preoperative atrial fibrillation. Patients with untreated atrial fibrillation showed higher mortality ('No AF': 2.2% versus 'AF no SA': 8.3% versus 'AF and SA': 3.2%; P-value 0.027) and increased postoperative pacemaker implantation rates ('No AF': 5.7% versus 'AF no SA': 15.6% versus 'AF and SA': 7.9%, P-value: 0.011). In a composite analysis of adverse events (Mortality, Bleeding, Stroke), the highest incidence was observed in patients with untreated atrial fibrillation, while patients with treated atrial fibrillation had similar outcomes as those without preoperative documented atrial fibrillation ('No AF': 9.6% versus 'AF no SA': 20.2% versus 'AF and SA' 3: 9.5%, P-value: 0.018). CONCLUSIONS: Concomitant surgical ablation should be considered in mitral valve surgery for atrial fibrillation, as it leads to similar mid-term outcomes compared to patients without preoperative documented atrial fibrillation.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Pregaldini F, Çelik M, Mosbahi S, et al. Perioperative and mid-term outcomes of mitral valve surgery with and without concomitant surgical ablation for atrial fibrillation: a retrospective analysis. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 39083003. doi:10.1093/icvts/ivae144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。